The panel is designed to facilitate easy and reliable screening for hepatitis C with other lab tests typically ordered early in pregnancy, Quest said in an Aug. 17 news release shared with Becker’s. The test is intended to close the gap in screening rates between Medicaid patients and the general population.
A Quest study published in Obstetrics & Gynecology found that less than 41 percent of pregnant people were screened for hepatitis C in 2021, and those under Medicaid were screened at rates 25-35 percent lower than those with commercial insurance.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
